←
Max Jaderberg551 posts
Max Jaderberg avatar✓

Max Jaderberg ✓

@maxjaderberg

President @IsomorphicLabs: solving disease with AI. Prev: Deepmind, Vision Factory (acq. Google), Oxford VGG.

◷ Joined April 2009▧ 111 Photos and videos
Max Jaderberg avatar
Max Jaderberg@maxjaderberg·Nov 17

An amazing moment at Iso as we close our Series C funding round! We founded Iso on the conviction that AI can transform biology into a programmable science. We are clearly seeing this play out internally with our models’ capabilities translating into new potential medicines for patients. This funding will supercharge our efforts, so we can push even deeper into the hard problems of understanding disease biology, engineering the most exquisite molecules possible, and bringing new drugs to patients who need them. Lots more to come!

0:37
Max Jaderberg avatar
Max Jaderberg@maxjaderberg·Nov 11

Beautiful work from our friends at DeepMind predicting the impact of DNA variants in different cell types!

1:07
Ben Jaderberg avatar
⟳ Max Jaderberg retweeted
Ben Jaderberg@benjaderberg·Nov 9

Our new paper, and my first since joining Google DeepMind, is on the arXiv today! Super exciting to see how we can leverage human expertise, Lean and AI to design better quantum algorithms including for full-scale scientific applications. arxiv.org/abs/2611.09822

Ben Jaderberg avatar
⟳ Max Jaderberg retweeted
Ben Jaderberg@benjaderberg·Oct 13

As we launch Gemini 4 Argon, we’re excited to share two standout results accelerating our quantum computing research at Google DeepMind, in collaboration with Google Quantum AI.

Max Jaderberg avatar
Max Jaderberg@maxjaderberg·Oct 7

To unlock the full impact of AI on human health we need to build both the technology and the biological dataset it will run on. We’ve been developing our AI, our drug design engine (IsoDDE), for the last 5 years. Today, by joining the Virtual Biology Initiative as a founding member, we will be part of a large effort to generate the AI-ready data that will power predictive biology models.

Max Jaderberg avatar
Max Jaderberg@maxjaderberg·Sep 29

The predictive capabilities from IsoDDE mean that not only can we create scientific hypotheses of new molecules, we can do a lot of predictive validation, so that when we do test in the real world, it has a much higher chance of success. More thoughts in the article here: isomorphiclabs.com/articles/… (5/5)

Max Jaderberg avatar
Max Jaderberg@maxjaderberg·Sep 29

This is one example but we’ve seen this sort of success dozens of times at this point from our engine: unlocking exquisitely engineered molecule designs and proving out unique biological hypotheses in the lab. And pushing hard to show the translation into the clinic to benefit patients. (4/5)

1:00
Max Jaderberg avatar
Max Jaderberg@maxjaderberg·Sep 29

At the end of the agent’s optimisation, we synthesise and test the final designs in the lab. The image below shows the functional response curve from the real world experimental testing of the output of the molecular search process. It shows the molecule has a strong functional effect and great properties compared to the best published molecule from the literature. (we don’t disclose the targets to protect our live programs at this stage) (3/5)

Post attachment
Max Jaderberg avatar
Max Jaderberg@maxjaderberg·Sep 29

Traditionally, each step along this path requires 1–3 months of work – manually designing screening libraries and making these molecules by teams of chemists, testing them by teams of biologists, and iteratively analysing the new data. Our drug design agent completes a similar progression in days by relying on our frontier AI predictive models rather than going into the real world. (2/5)

Post attachment
Max Jaderberg avatar
Max Jaderberg@maxjaderberg·Sep 29

Here’s a visualisation I built of the generative design agent we use every day at Iso. IsoDDE takes the goals of our drug designers and works autonomously to produce a set of pareto best molecules. Throughout the core generative design and optimisation process you can see a visualisation of the agent’s attention (heatmap) as it balances exploration-exploitation across chemical space (here just umap visualised) to find the best molecules (greener = better) I’ve pulled out only one pareto-best molecule to exemplify this process, but I’ll showcase in a later video how we do this at scale (1/5)

0:50
Max Jaderberg avatar
Max Jaderberg@maxjaderberg·Sep 29

Breakthroughs in frontier science rarely come from a sudden stroke of luck. Every major leap in AI drug design is the product of years of method development, rigorous engineering, and learning from what came before. Witnessing the rapid advances in deep reinforcement learning and frontier AI capabilities led to a deep conviction: we could apply these same computational principles to other complex fields, like the engineering of new medicines. That thinking led to the formation of Isomorphic Labs in 2021. Now, five years on, we have compelling evidence that our AI can unlock therapeutics to a wide range of disease classes. We are confident this technology will fundamentally impact how new medicines are created, from early discovery all the way through development. In this article, I share the massive opportunity we have to transform human health with AI, and offer a look at the real, measurable progress we’re already making today. isomorphiclabs.com/articles/…

Post attachment
Max Jaderberg avatar
Max Jaderberg@maxjaderberg·Sep 10

Looking forward to talking about how we move past the current AI hype and build systems that can improve human health. See you in November!

Post attachment
Žiga Avsec avatar
⟳ Max Jaderberg retweeted
Žiga Avsec@Avsecz·Sep 8

Excited to release AlphaGenome Atlas 🧬 We used AlphaGenome to predict the regulatory impact of all 9B possible SNVs in the human genome. We collaborated with amazing scientists to analyze and apply it, and developed a portal to browse the genome using this new lens 🔬 🌐 Portal: alphagenome.google/atlas 📖 Blog: goo.gle/4heuCvn 📄 Preprint: deepmind.google/blog/alphage… 🧵 1/6

3:36
Isomorphic Labs avatar
⟳ Max Jaderberg retweeted
Isomorphic Labs@IsomorphicLabs·Aug 27

The prediction: 5 years for the industry to realise AI is essential in drug design and development – @maxjaderberg. While this episode aired a year ago, we’ve been building for almost 5 years already, and have always held the conviction that our AI will redefine how new medicines are made.

0:15
Max Jaderberg avatar
Max Jaderberg@maxjaderberg·Aug 13

Interesting to see a benchmark for discovery that seems to have a meaningful axis of difficulty (at least wrt frontier models). And given that humans can solve first try.

Post attachment
Max Jaderberg avatar
Max Jaderberg@maxjaderberg·Aug 7

There's never been a better time to lean into using frontier AI towards the most important problems in the world, and at a place that is so singularly focused on achieving that impact like Isomorphic